The Cigna Group filed its Form 10-Q for the quarterly period ended September 30, 2026 with the Securities and Exchange Commission on November 5, 2026, reporting total revenues of $73,683 million for the third quarter and shareholders' net income of $1,442 million.

Key Highlights

  • Total revenues: $73,683 million for the three months ended September 30, 2026, compared with $69,748 million in the same period of 2025, according to the filing.
  • Shareholders' net income: $1,442 million for Q3 2026, versus $1,868 million in Q3 2025, as reported.
  • Diluted earnings per share: $5.47 for the three months ended September 30, 2026, compared with $6.98 in the prior-year quarter.
  • Nine-month total revenues: $213,845 million for the nine months ended September 30, 2026, up from $202,428 million in the nine months ended September 30, 2025.
  • Total assets: $157,644 million as of September 30, 2026, compared with $157,919 million as of December 31, 2025.
  • Common dividend declared: $1.56 per share for the three months ended September 30, 2026, per the equity statement.
  • Shares outstanding: 263,502,561 shares of common stock as of October 30, 2026, as stated on the cover page.

The Cigna Group's Third-Quarter 2026 Financial Results

The Cigna Group (NYSE:CI) disclosed its unaudited quarterly financial results in a Form 10-Q covering the period ended September 30, 2026. According to the filing, total revenues for the third quarter reached $73,683 million, driven primarily by pharmacy revenues of $58,982 million and premiums of $9,885 million. The company reported income from operations of $2,396 million for the quarter, compared with $2,578 million in Q3 2025.

The filing reported net income of $1,698 million for the three months ended September 30, 2026. After subtracting $256 million attributable to noncontrolling interests, shareholders' net income was $1,442 million, translating to basic earnings per share of $5.49 and diluted earnings per share of $5.47. For the nine months ended September 30, 2026, shareholders' net income totaled $4,756 million, with diluted earnings per share of $18.02, the filing stated.

On the balance sheet, the company reported total assets of $157,644 million as of September 30, 2026, with goodwill of $45,537 million and other intangible assets of $26,755 million. Total shareholders' equity stood at $43,383 million, up from $41,713 million as of December 31, 2025. Long-term debt was reported at $28,849 million, compared with $30,871 million at year-end 2025. During Q3 2026, the company repurchased $252 million of common stock and declared a common dividend of $1.56 per share, according to the consolidated statements of changes in total equity.

What Was Disclosed

The Cigna Group filed its unaudited Form 10-Q for the quarter ended September 30, 2026, disclosing income statement, balance sheet, cash flow, and equity data for Q3 and the nine months year-to-date, along with share count and dividend information.